home / lobbying

lobbying_activities

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

310 rows where filing_period = "second_quarter", filing_year = 2023 and issue_code = "MED" sorted by filing_year descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: filing_type, is_termination, received_date (date)

issue_code 1

  • MED · 310 ✖

filing_year 1

  • 2023 · 310 ✖

filing_period 1

  • second_quarter · 310 ✖
id filing_uuid filing_type registrant_name registrant_id client_name filing_year ▲ filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
2957577 PARDES BIOSCIENCES, INC. 7b178cfd-76ff-4ab0-bfa0-f3bee1a34931 2T PARDES BIOSCIENCES, INC. 401106493 PARDES BIOSCIENCES, INC. 2023 second_quarter MED NIH funding for clinical trials Natl Institutes of Health (NIH)   120000 0 1 2023-04-12T10:26:43-04:00
2997804 INTERNATIONAL CHIROPRACTORS ASSOCIATION b8cd1bc0-6e62-45e0-a693-8fcae22ff5e8 Q2 INTERNATIONAL CHIROPRACTORS ASSOCIATION 401105988 INTERNATIONAL CHIROPRACTORS ASSOCIATION 2023 second_quarter MED The importance in increasing research resources to both chiropractic institutions, practice-based researchers, and non profits involved in advancing research. HOUSE OF REPRESENTATIVES,SENATE   5500 0 0 2023-06-13T11:00:41-04:00
2998233 AUBURN HEALTH STRATEGIES, LLC 94d69b50-8282-418d-a8c8-7637a8fc839a Q2 AUBURN HEALTH STRATEGIES, LLC 292697 AMERICAN PROFICIENCY INSTITUTE 2023 second_quarter MED proficiency testing for clinical laboratories Health & Human Services, Dept of (HHS)     0 0 2023-06-30T17:58:58-04:00
2998256 FRANCIS EDWARD & CRONIN, INC. 29b3d67d-bf04-4a3e-9bb9-c2393db0dc51 Q2 FRANCIS EDWARD & CRONIN, INC. 311314 CURE ALZHEIMER'S FUND 2023 second_quarter MED Legislation related to Alzheimer's disease research Environmental Protection Agency (EPA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 20000   0 0 2023-07-01T14:00:03-04:00
2998257 FRANCIS EDWARD & CRONIN, INC. 5bdc849f-f4c5-496c-9817-74dd7acf5bfd Q2 FRANCIS EDWARD & CRONIN, INC. 311314 PATH DECISION SUPPORT SOFTWARE, LLC 2023 second_quarter MED Legislation related to Diabetes Treament HOUSE OF REPRESENTATIVES,SENATE     0 0 2023-07-01T14:02:29-04:00
2998388 OCAL LOBBYING GROUP 824cfa81-91ba-4bce-be6d-d59d66b25373 Q2 OCAL LOBBYING GROUP 401106825 SAMERA S.A. 2023 second_quarter MED Obtain funding for Tuberculosis monitoring. Natl Institutes of Health (NIH)     0 0 2023-07-03T12:48:50-04:00
2998649 MARSHALL BRACHMAN 1bd69e23-1db3-418e-ba64-bf9fb5753a73 Q2 MARSHALL BRACHMAN 6848 BAYLOR SCOTT AND WHITE HEALTH -- FORMERLY BAYLOR HEALTH CARE SYSTEM 2023 second_quarter MED support funding for medical research programs HOUSE OF REPRESENTATIVES,SENATE 33000   0 0 2023-07-04T15:12:57-04:00
2998852 EMERGENT STRATEGIES 36b08c2b-8d6d-4a81-a641-ec3f8aa057f6 Q2 EMERGENT STRATEGIES 401104778 ADVAMED:ADVANCED MEDICAL TECHNOLOGY ASSOCIATION 2023 second_quarter MED Health tax issues and trade, Issues related to Small Business Innovation Research Program. PAHPA Reauthorization HOUSE OF REPRESENTATIVES,SENATE 45000   0 0 2023-07-05T10:31:33-04:00
2998919 HELIX, INC. 2de164b0-0392-498a-9878-a907a22d0089 Q2 HELIX, INC. 401106164 HELIX, INC. 2023 second_quarter MED COVID-19, Disease X and other respiratory pathogen sequencing and countermeasure development Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,White House Office   40000 0 0 2023-07-05T12:02:25-04:00
2998928 FRANCIS EDWARD & CRONIN, INC. 6d2ad027-951e-478b-ace5-c7a3e215b58d 2A FRANCIS EDWARD & CRONIN, INC. 311314 USAGAINSTALZHEIMER'S 2023 second_quarter MED Legislation related to the treatment, detection, and prevention of Alzheimer's disease HOUSE OF REPRESENTATIVES,SENATE     0 0 2023-07-05T12:08:05-04:00
2998959 MAGILL ASSOCIATES, LLC 5a3d7add-e5af-4943-a9ef-926090e703e6 Q2 MAGILL ASSOCIATES, LLC 401103511 THE LIVINGSTON GROUP ON BEHALF OF INNOVATIVE VACCINE TECHNOLOGIES 2023 second_quarter MED FY 2023 and FY 2024 appropriations for the development of a synthetic vaccine Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2023-07-05T12:51:01-04:00
2999139 AMERICAN COLLEGE OF CLINICAL PHARMACY 1dcbc5ab-ac19-4621-ad46-7057ddea9c82 Q2 AMERICAN COLLEGE OF CLINICAL PHARMACY 57258 AMERICAN COLLEGE OF CLINICAL PHARMACY 2023 second_quarter MED Focus interactions with the Agency for Healthcare Research and Quality (AHRQ) on the issue of Quality of Medication Therapy Management Services delivered programs authorized by the Patient Protection and Affordable Care Act (PPACA PL 111-148) and Medicare Part D plans. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   144981 0 0 2023-07-06T04:40:27-04:00
2999267 UNIVERSITY OF KENTUCKY 3e996b14-4bab-4471-b5e4-fd4431dd9f38 Q2 UNIVERSITY OF KENTUCKY 400287372 UNIVERSITY OF KENTUCKY 2023 second_quarter MED Barriers to research with Schedule 1 drugs NCI funding for FY24 HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE   168800 0 0 2023-07-06T11:18:33-04:00
2999299 REPUBLIC CONSULTING, LLC 09db606d-59fe-4cca-9856-be82ae11a84b Q2 REPUBLIC CONSULTING, LLC 401016871 IQVIA 2023 second_quarter MED Monitor Health Data Policy. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2023-07-06T11:42:46-04:00
2999427 AMERICA'S BLOOD CENTERS 15afcee4-5ed3-4f1c-af56-eb0b28cc3afa Q2 AMERICA'S BLOOD CENTERS 3834 AMERICA'S BLOOD CENTERS 2023 second_quarter MED Value of Blood/Reimbursement, laboratory developed tests Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   20000 0 0 2023-07-06T16:07:22-04:00
2999445 IMPACT MANAGEMENT GROUP 37b1dee4-140f-45b6-af77-352e33e0bd79 Q2 IMPACT MANAGEMENT GROUP 401104137 ARKANSAS RESEARCH ALLIANCE 2023 second_quarter MED On behalf of client support continued and future funding for clinical research programs in Arkansas HOUSE OF REPRESENTATIVES,SENATE     0 0 2023-07-06T16:29:20-04:00
3000021 IMPACT MANAGEMENT GROUP b58eca4d-6288-4cd4-9d4a-94f7a265cf2e Q2 IMPACT MANAGEMENT GROUP 401104137 CENTRAL ARKANSAS RADIATION THERAPY INSTITUTE, INC. 2023 second_quarter MED Supporting the passage of H.R. 3173 - Improving Seniors' Timely Access to Care Act of 2021 HOUSE OF REPRESENTATIVES     0 0 2023-07-08T16:48:23-04:00
3000191 THE HARRIS FIRM 083f7764-0c82-4c92-bf4c-b7d9b73d0357 Q2 THE HARRIS FIRM 68376 HOLISTIC INDUSTRIES INC. 2023 second_quarter MED Issues pertaining to cannabis CSA scheduling. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2023-07-09T23:05:01-04:00
3000258 IPOLICY SOLUTIONS a90b0068-f303-4c0f-8619-b2c0cc64d200 Q2 IPOLICY SOLUTIONS 401105127 ASSOCIATION FOR MOLECULAR PATHOLOGY 2023 second_quarter MED No bill #: Verified Innovative Testing in American Laboratories Act H.R.2369 - VALID Act of 2023 HOUSE OF REPRESENTATIVES,SENATE 58000   0 0 2023-07-10T09:48:32-04:00
3000277 IPOLICY SOLUTIONS cd957248-35fe-4fc7-822e-ebb4eb8b94b8 Q2 IPOLICY SOLUTIONS 401105127 INVITAE INC. 2023 second_quarter MED H.R.2369 - VALID Act of 2023 FDA Guidance, Docket No. FDA-2022-D-2983 for Considerations for the Design and Conduct of Externally Controlled Trials for Drug and Biological Products FDA public meeting, FDA-2018-N-4002 Electronic Submission of Adverse Event Reports to FAERS Using ICH E2B(R3) Standards FDA guidance, Docket No. FDA-2023-D-0110: Clinical Trial Considerations to Support Accelerated Approval of Oncology Therapeutics Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 90000   0 0 2023-07-10T10:03:38-04:00
3000525 PENN AVENUE PARTNERS 82de7f35-aa65-4315-9956-a12a600b7ac8 Q2 PENN AVENUE PARTNERS 400918672 CLIFFSIDE LABS, LLC 2023 second_quarter MED Policy and regulatory matters related to the clinical laboratory industry. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2023-07-10T16:22:01-04:00
3000595 MICHAEL N. MCCARTY LAW OFFICE PLLC 71cc7aee-eb64-4d93-ac61-ff5e4ed32406 Q2 MICHAEL N. MCCARTY LAW OFFICE PLLC 401104300 AMERICAN MEDICAL TECHNOLOGISTS 2023 second_quarter MED Support funding for the Centers for Disease Control (CDC) Environmental Health Laboratory to "harmonize" clinical laboratory test results; support funding for CDC's Environmental Health Laboratory to establish pediatric reference intervals for diagnostic laboratory tests performed on children; support enhanced funding for CDC's Advanced Molecular Detection program; monitor legislation to regulate laboratory-developed in vitro diagnostic tests, including the Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2023 (H.R. 2369). HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2023-07-10T18:58:53-04:00
3000729 BEN BARNES GROUP LP eb53e242-c743-41ac-b7b9-4a97d105fa6b Q2 BEN BARNES GROUP LP 5415 HUNTSMAN CORPORATION 2023 second_quarter MED CMS Medicare HOUSE OF REPRESENTATIVES,SENATE 18750   0 0 2023-07-11T10:45:31-04:00
3000740 BEN BARNES GROUP LP 55d3bee6-f03a-4380-8b38-9f4e1ba51dc5 Q2 BEN BARNES GROUP LP 5415 ENVIGO RMS LLC 2023 second_quarter MED Medical/Disease Research HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2023-07-11T10:52:52-04:00
3000798 BLUEBIRD STRATEGIES d31c4e8d-4e72-41e8-9012-cb333a55766e Q2 BLUEBIRD STRATEGIES 401105447 MYRIAD GENETICS, INC. 2023 second_quarter MED Legislation to regulate clinical labs under CLIA and FDA. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2023-07-11T11:25:08-04:00
3000830 BLUEBIRD STRATEGIES 7df98ad4-efd5-40db-92f4-839a0be5e70b Q2 BLUEBIRD STRATEGIES 401105447 MYOTONIC 2023 second_quarter MED Increasing funding for Myotonic Dystrophy research. Fiscal Year 2024 defense appropriations legislation. Peer Review Medical Research Program and Congressional Directed Medical Research Program. Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE     0 0 2023-07-11T11:43:51-04:00
3000938 COMPASS MANAGEMENT PARTNERS, INC. 01f2d35f-82ca-4328-afe3-b4afae0aa504 Q2 COMPASS MANAGEMENT PARTNERS, INC. 401105171 THE LIVING LEGACY FOUNDATION OF MARYLAND 2023 second_quarter MED Regulations impacting accountability requirements at organ procurement organizations; organ donation matters   20000   0 0 2023-07-11T12:52:36-04:00
3000946 OKLAHOMA STATE UNIVERSITY 0bbed217-c3bc-4743-91ea-6028ff349b69 Q2 OKLAHOMA STATE UNIVERSITY 30165 OKLAHOMA STATE UNIVERSITY 2023 second_quarter MED Graduate Medical Education funding; Teaching Health Center GME reauthorization and funding; indigenous health centers; AHEC program; MSE program; other extraneous issues as they may arise HOUSE OF REPRESENTATIVES,SENATE   40000 0 0 2023-07-11T12:59:24-04:00
3000952 COMPASS GOVERNMENT RELATIONS PARTNERS, LLC 71303475-b0d2-4726-8fc9-7951ee941767 Q2 COMPASS GOVERNMENT RELATIONS PARTNERS, LLC 401106533 COALITION FOR INNOVATIVE LABORATORY TESTING, INC. 2023 second_quarter MED VALID Act of 2023 (H.R.2369); Provisions that negatively impact Clinical Laboratory Improvement Amendments (CLIA)-approved laboratory businesses HOUSE OF REPRESENTATIVES,SENATE     0 0 2023-07-11T13:00:18-04:00
3001633 SQUIRE PATTON BOGGS 4f76298d-f687-44fd-9799-2b2f62d0e4d0 Q2 SQUIRE PATTON BOGGS 30906 LA MAESTRA FOUNDATION ON BEHALF OF LA MAESTRA FAMILY CLINIC, INC. 2023 second_quarter MED Funding support for federally qualified health centers; reauthorization of programs HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2023-07-12T14:54:54-04:00
3001677 THE PETRIZZO GROUP, INC. 0ccdb42f-6464-4d41-94ba-c7f6d8133f66 Q2 THE PETRIZZO GROUP, INC. 305932 DYSAUTONOMIA INTERNATIONAL 2023 second_quarter MED Advocate for NIH research funding for dysautonomia disorders, specifically Postural Orthostatic Tachycardia Syndrome (POTS) and funding to examine the correlation between POTS and Long COVID. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 45000   0 0 2023-07-12T15:07:36-04:00
3001722 THE PETRIZZO GROUP, INC. f8055f7b-b808-4c2e-aa6e-72e2a238c297 Q2 THE PETRIZZO GROUP, INC. 305932 SEATTLE CHILDREN'S HOSPITAL RESEARCH AND FOUNDATION 2023 second_quarter MED Increased funding for pediatric medical research HOUSE OF REPRESENTATIVES,SENATE 90000   0 0 2023-07-12T15:19:51-04:00
3001832 SQUIRE PATTON BOGGS 04a8df23-f2e5-4225-9135-b3a86f82ca61 Q2 SQUIRE PATTON BOGGS 30906 NATIONAL CANNABIS ROUNDTABLE 2023 second_quarter MED Reforming federal law and policy governing medical research, financial transactions, and tax deductions applicable to cannabis and allowing states and territories to set and enforce their own laws governing cannabis use. HOUSE OF REPRESENTATIVES,SENATE 80000   0 0 2023-07-12T16:05:06-04:00
3002087 CORNERSTONE GOVERNMENT AFFAIRS, INC. 8ca63a93-103c-47a4-a06c-bc12e267d594 Q2 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 PULMONARY FIBROSIS FOUNDATION 2023 second_quarter MED Appropriations for research on pulmonary fibrosis HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2023-07-12T22:33:05-04:00
3003425 CORNERSTONE GOVERNMENT AFFAIRS, INC. 2271a626-b306-42eb-bdd9-a75010ebcfb8 Q2 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 AMERICAN SOCIETY FOR RADIATION ONCOLOGY 2023 second_quarter MED Discussions regarding patient access to radiation oncology. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES 50000   0 0 2023-07-13T23:56:39-04:00
3003590 EFB ADVOCACY, LLC e3432ac6-e172-490a-91eb-9ed2facd1779 Q2 EFB ADVOCACY, LLC 401104430 UNITED FOR MEDICAL RESEARCH 2023 second_quarter MED Funding Issues related to the National Institutes of Health HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2023-07-14T10:21:14-04:00
3003793 WILLIAMS AND JENSEN, PLLC 83b739cc-4ed7-46d9-a7e0-5b2843875f00 2T WILLIAMS AND JENSEN, PLLC 41454 ADVANCED MEDICAL TECHNOLOGY ASSOCIATION (ADVAMED) 2023 second_quarter MED Issues related to FDA regulation of medical devices, including the VALID Act. HOUSE OF REPRESENTATIVES,SENATE 30000   0 1 2023-07-14T11:45:15-04:00
3003798 WILLIAMS AND JENSEN, PLLC 5566ab6d-a8dc-41c5-84a5-fbce1652ec98 2T WILLIAMS AND JENSEN, PLLC 41454 BIOBOT ANALYTICS 2023 second_quarter MED General education to advance policies that support wastewater-based epidemiology and wastewater surveillance data analytic technology. HOUSE OF REPRESENTATIVES,SENATE,White House Office 20000   0 1 2023-07-14T11:47:54-04:00
3003801 SPINA BIFIDA ASSOCIATION OF AMERICA 3e7efa7a-40ea-4c4f-bc53-6d5af4292e6a Q2 SPINA BIFIDA ASSOCIATION OF AMERICA 46665 SPINA BIFIDA ASSOCIATION OF AMERICA 2023 second_quarter MED Appropriations Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE   45536 0 0 2023-07-14T11:49:20-04:00
3003812 WILLIAMS AND JENSEN, PLLC ebd85b00-efc8-41c8-a2db-5f45fea5df28 2T WILLIAMS AND JENSEN, PLLC 41454 VERTEX PHARMACEUTICALS INCORPORATED 2023 second_quarter MED General education about federal policies impacting pharmaceutical development, approval, and reimbursement. HOUSE OF REPRESENTATIVES,SENATE 20000   0 1 2023-07-14T11:54:22-04:00
3003852 DREXEL UNIVERSITY c540fae6-c0a4-4125-9fe5-8b622b1627dd Q2 DREXEL UNIVERSITY 40032273 DREXEL UNIVERSITY 2023 second_quarter MED Advocacy around Medicaid reimbursements for high medicaid medical facilities HOUSE OF REPRESENTATIVES,SENATE   81000 0 0 2023-07-14T12:11:05-04:00
3003989 SQUIRE PATTON BOGGS 70e89ec7-d3b6-4f72-a46a-cedfb8ef957f Q2 SQUIRE PATTON BOGGS 30906 ALLIANCE FOR BIOSECURITY 2023 second_quarter MED Preparedness and response as it relates to Biosecurity. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 80000   0 0 2023-07-14T13:14:18-04:00
3004189 WILLIAMS AND JENSEN, PLLC f76bccc4-40f2-4dcf-b171-da8493d02ffe Q2 WILLIAMS AND JENSEN, PLLC 41454 THE JED FOUNDATION 2023 second_quarter MED General education about mental health and suicide prevention programs. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2023-07-14T14:32:01-04:00
3004288 TIBER CREEK GROUP 6b9efc91-f849-49d2-a635-2870de794827 Q2 TIBER CREEK GROUP 20744 JAZZ PHARMACEUTICALS 2023 second_quarter MED Issues related to cannabis research; issues related to the FDA; issues related to Cannabis research at Health and Human Services. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2023-07-14T14:54:22-04:00
3004432 F. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES 1e1f7e06-dce3-4041-9a8b-a7ff4329cb72 Q2 F. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES 18411 F HOFFMANN-LA ROCHE LTD AND ITS AFFILIATES 2023 second_quarter MED (MMM) Clinical Lab Fee Schedule H.R. 2377 and S. 1000. Saving Access to Laboratory Services Act (SALSA), and HR 1691 Ensuring Patient Access to Critical Breakthrough Products Act of 2023 HOUSE OF REPRESENTATIVES,SENATE   140000 0 0 2023-07-14T15:50:56-04:00
3004681 AVENUE SOLUTIONS 85a9722b-5af2-4ade-9b24-5b21382285d7 2T AVENUE SOLUTIONS 72111 ORGANIZE 2023 second_quarter MED Transplantable organ procurement reform; Revisions to the Outcome Measure Requirements for Organ Procurement Organizations; Final Rule (42 CFR, Part 486) HOUSE OF REPRESENTATIVES,SENATE 30000   0 1 2023-07-14T17:26:24-04:00
3004719 STANFORD UNIVERSITY 032e4d92-a1a8-460d-b0d8-6392d3a48224 Q2 STANFORD UNIVERSITY 36492 STANFORD UNIVERSITY 2023 second_quarter MED HR 2389 Resident Physician Shortage Reduction Act of 2023 HOUSE OF REPRESENTATIVES,SENATE   70000 0 0 2023-07-14T17:56:59-04:00
3004923 CORNERSTONE GOVERNMENT AFFAIRS, INC. c46fc668-1b2d-4bd8-9d2e-d5ee9160cade Q2 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 HAZELDEN BETTY FORD FOUNDATION 2023 second_quarter MED Educate key government stakeholders on Hazelden Betty Ford Foundation activities in support of substance use and mental health for US Service members and Veterans. Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2023-07-14T21:41:22-04:00
3004943 CORNERSTONE GOVERNMENT AFFAIRS, INC. c76839ff-61e9-4202-a08e-4ce969beab55 Q2 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 ADVANCED MEDICAL TECHNOLOGY ASSOCIATION 2023 second_quarter MED Congressional outreach related to health care issues. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2023-07-14T22:26:17-04:00
3005006 POWERS PYLES SUTTER & VERVILLE, P.C. 8292d3ad-8876-4fa6-a312-b2453c558b58 Q2 POWERS PYLES SUTTER & VERVILLE, P.C. 32008 PIH HEALTH FOUNDATION 2023 second_quarter MED Consolidated Appropriations Act, 2023, H.R. 2617, now P.L. 117-328 FY 2024 House, Senate Departments of Labor, Health & Human Services, and Education and Related Agencies Appropriations Bills FY 2024 House, Senate Department of Agriculture Appropriations Bills FY 2024 House, Senate Commerce and Justice, Science and Related Agencies Appropriations Bills FY 2024 House, Senate Financial Services and General Government Appropriations Bills FY 2024 House, Senate Department of Homeland Security Appropriations Bills Pursuit of Grants with Federal Agencies House, Senate Legislation to Train More Primary Care and Other Providers House, Senate Legislation to Fund Substance Use Disorder and Behavioral Health Programs House, Senate Legislation to Fund FCC Broadband and Other Telehealth House, Senate Legislation to Implement Electronic Provider Consultations(E-Consults) with Related Telemedicine in Hospitals House, Senate Infrastructure Bills Agriculture, Dept of (USDA),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Commerce, Dept of (DOC),Federal Communications Commission (FCC),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA) 30000   0 0 2023-07-15T10:27:28-04:00
3005025 POWERS PYLES SUTTER & VERVILLE, P.C. a0d9e8bb-f964-43e4-a25a-db612fa8c75c Q2 POWERS PYLES SUTTER & VERVILLE, P.C. 32008 CORNERSTONE CARE, INC. 2023 second_quarter MED FY 2024 House, Senate Departments of Labor, Health & Human Services, and Education and Related Agencies Appropriations Bills FY 2024 House, Senate Department of Agriculture Appropriations Bills FY 2024 House, Senate Department of Homeland Security Appropriations Bills FY 2024 House, Senate Commerce and Justice, Science and Related Agencies Appropriations Bills Pursuit of Grants with Federal Agencies House, Senate Legislation to Train More Primary Care and Other Providers House, Senate Legislation to Fund Substance Use Disorder and Behavioral Health Programs House, Senate Legislation to Fund FCC Broadband and Other Telehealth House, Senate Infrastructure Bills Appalachian Regional Commission,Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Commerce, Dept of (DOC),Economic Development Administration,Federal Communications Commission (FCC),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA),Treasury, Dept of     0 0 2023-07-15T10:59:47-04:00
3005035 POWERS PYLES SUTTER & VERVILLE, P.C. 810d9fbd-cdb3-4c6b-9619-5ecc5da9e6c8 Q2 POWERS PYLES SUTTER & VERVILLE, P.C. 32008 GATEWAYS HOSPITAL & MENTAL HEALTH CENTER FOUNDATION 2023 second_quarter MED Consolidated Appropriations Act, 2023, H.R. 2617, now P.L. 117-328 FY 2024 House, Senate Departments of Labor, Health & Human Services, and Education and Related Agencies Appropriations Bills FY 2024 House, Senate Department of Agriculture Appropriations Bills FY 2024 House, Senate Department of Commerce and Justice, Science and Related Appropriations Bills FY 2024 House, Senate Department of Homeland Security Appropriations Bills FY 2024 House, Senate Financial Services and General Government Appropriations Bills FY 2024 House, Senate Departments of Transportation, Housing and Urban Development and Related Agencies Appropriations Bills Pursuit of Grants with Federal Agencies House, Senate Legislation to Train More Behavioral Health and Related Providers House, Senate Legislation to Fund Substance Use Disorder Prevention and Treatment House, Senate Legislation to Fund Behavioral Health Care Programs House, Senate Legislation to Fund FCC Broadband and Other Telehealth House, Senate Infrastructure Bills Administration for Children & Families (ACF),Agency for Healthcare Research & Quality (AHRQ),Agriculture, Dept of (USDA),Bureau of Justice Assistance,Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Federal Communications Commission (FCC),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Housing & Urban Development, Dept of (HUD),Justice, Dept of (DOJ),Office of Justice Program,SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA) 20000   0 0 2023-07-15T11:18:31-04:00
3005042 POWERS PYLES SUTTER & VERVILLE, P.C. 1acf41d7-215d-4acd-b0fd-109a0fb14959 Q2 POWERS PYLES SUTTER & VERVILLE, P.C. 32008 HERBERT J. THOMAS MEMORIAL HOSPITAL ASSOCIATION (FKA THOMAS HEALTH) 2023 second_quarter MED Consolidated Appropriations Act, FY 2022, H.R. 2741, now P.L. 117-103 (FY 2022 CDS Implementation) FY 2024 House, Senate Departments of Labor, Health & Human Services, and Education and Related Agencies Appropriations Bills FY 2024 House, Senate Department of Agriculture Appropriations Bills FY 2024 House, Senate Department of Commerce and Justice, Science and Related Appropriations Bills FY 2024 House, Senate Department of Homeland Security Appropriations Bills FY 2024 House, Senate Financial Services and General Government Appropriations Bills FY 2024 House, Senate Departments of Transportation, Housing and Urban Development and Related Agencies Appropriations Bills Pursuit of Grants with Federal Agencies House, Senate Legislation to Train More Primary Care, Behavioral Health and Related Providers House, Senate Legislation to Fund Substance Use Disorder Prevention and Treatment House, Senate Legislation to Fund Behavioral Health Programs House, Senate Legislation to Fund FCC Broadband and Other Telehealth House, Senate Legislation to Implement Electronic Provider Consultations (E-Consults) with Related Telemedicine/Telehealth in Hospitals House, Senate Infrastructure Bills Administration for Children & Families (ACF),Administration on Aging,Agency for Healthcare Research & Quality (AHRQ),Agriculture, Dept of (USDA),Appalachian Regional Commission,Bureau of Labor Statistics (BLS),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Commerce, Dept of (DOC),Economic Development Administration,Federal Communications Commission (FCC),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA),Treasury, Dept of 60000   0 0 2023-07-15T11:41:06-04:00
3005066 POWERS PYLES SUTTER & VERVILLE, P.C. 7421db6c-bf64-42f2-a975-23f578185d54 Q2 POWERS PYLES SUTTER & VERVILLE, P.C. 32008 MOSES WEITZMAN HEALTH SYSTEM, INC. 2023 second_quarter MED Consolidated Appropriations Act, 2023, H.R. 2617, now P.L. 117-328 FY 2024 House, Senate Departments of Labor, Health & Human Services, and Education and Related Agencies Appropriations Bills FY 2024 House, Senate Department of Agriculture Appropriations Bills FY 2024 House, Senate Department of Commerce and Justice, Science and Related Appropriations Bills FY 2024 House, Senate Department of Homeland Security Appropriations Bills FY 2024 House, Senate Financial Services and General Government Appropriations Bills FY 2024 House, Senate Departments of Transportation, Housing and Urban Development and Related Agencies Appropriations Bills Pursuit of Grants with Federal Agencies House, Senate Legislation to Authorize and Fund Postgraduate Nurse Practitioner Residency and Fellowship Training Programs, Postgraduate Psychiatric Fellowships, Medical Assistant Training Programs, and other Health Workforce Training Programs House, Senate Legislation to Fund Education, Training and Technical Assistance in Support of the National Health Workforce House, Senate Legislation to Fund Substance Use Disorder Prevention and Treatment House, Senate Legislation to Fund Behavioral Health Programs and Providers House, Senate Legislation to Fund FCC Broadband and Other Telehealth House, Senate Legislation to Implement Electronic Provider Consultations (E-Consults) with Related Telemedicine in Health Centers, Rural Health Clinics, and Elsewhere House, Senate Infrastructure Bills Administration for Children & Families (ACF),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Education, Dept of,Employment & Training Administration,Federal Communications Commission (FCC),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA),Veterans Affairs, Dept of (VA) 10000   0 0 2023-07-15T13:07:47-04:00
3005424 CORNERSTONE GOVERNMENT AFFAIRS, INC. d1ca60a5-ace2-46a9-bd4e-a3b0bf290eed Q2 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 CHILDREN'S NATIONAL MEDICAL CENTER 2023 second_quarter MED Health-related issues including reimbursement, research, public-health & clinical care. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office 50000   0 0 2023-07-15T22:49:17-04:00
3005431 CORNERSTONE GOVERNMENT AFFAIRS, INC. ca345c48-b645-4b6c-bf1a-1e46b7d2b522 Q2 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 CITY OF HOPE MEDICAL CENTER 2023 second_quarter MED Issues related to Medicare/Medicaid reimbursement and clinical research. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2023-07-15T22:51:18-04:00
3005611 FORBES-TATE 30c05f56-b360-42da-91ad-52aedff5ea03 Q2 FORBES-TATE 400976792 AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION 2023 second_quarter MED Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2023-07-16T11:35:37-04:00
3005643 FORBES-TATE a9c2ca33-dd11-44fd-a26f-7c3705e8907b Q2 FORBES-TATE 400976792 AMGEN USA, INC. 2023 second_quarter MED Issues related to Biosimilars; Issues related to drug pricing; Issues related to H.R. 5376 - Inflation Reduction Act of 2022 (P.L. 117-169). HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2023-07-16T11:50:28-04:00
3005724 FORBES-TATE 40e0438d-caea-410c-b931-a58bc358b4c6 Q2 FORBES-TATE 400976792 CALIFORNIA LIFE SCIENCES ASSOCIATION 2023 second_quarter MED Issues related to the life sciences industry; Issues related to drug pricing; Issues related to the implementation of H.R. 5376 - Inflation Reduction Act of 2022(P.L. 117-169). HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2023-07-16T12:38:22-04:00
3005755 FORBES-TATE 26dd9370-556a-46d2-8175-d648175ba84e Q2 FORBES-TATE 400976792 COALITION FOR CANNABIS POLICY, EDUCATION, AND REGULATION 2023 second_quarter MED Issues pertaining to government-wide federal regulation of cannabis. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2023-07-16T13:08:52-04:00
3005765 FORBES-TATE f97c0594-da97-4321-8563-744b50521a84 Q2 FORBES-TATE 400976792 CSL BEHRING 2023 second_quarter MED Issues related to Rx pricing. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2023-07-16T13:24:08-04:00
3005856 CORNERSTONE GOVERNMENT AFFAIRS, INC. ea8681da-5eec-43fb-a682-ffd995bfd943 Q2 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 JOHNS HOPKINS UNIVERSITY 2023 second_quarter MED Advised on fiscal year 2024 appropriations; Medicare reimbursement; Graduate Medical Education; higher education; price transparency; telehealth; Committee on Foreign Investment in the United States; public health; Advanced Research Projects Agency for Health; Pandemic preparedness; and clinical trial legislative and regulatory issues. HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE 60000   0 0 2023-07-16T15:04:16-04:00
3006096 CORNERSTONE GOVERNMENT AFFAIRS, INC. 8b53e2a6-a0fe-44bf-907d-1e6769c42048 Q2 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 GINKGO BIOWORKS, INC. 2023 second_quarter MED Educated key government stakeholders on Ginkgo Bioworks capabilities in support of wastewater surveillance, biomanufacturing, and critical minerals. Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE 90000   0 0 2023-07-16T21:53:54-04:00
3006098 CORNERSTONE GOVERNMENT AFFAIRS, INC. af368331-c80e-40f7-b932-2a9418eba074 Q2 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 ADVANCED MATERIALS AND DEVICES, INC. 2023 second_quarter MED Educated key government stakeholders on AMADs products applicable to the military. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2023-07-16T21:58:32-04:00
3006101 CORNERSTONE GOVERNMENT AFFAIRS, INC. 60024013-751c-49b9-8680-e9b72f63f68f Q2 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 NIRSENSE, LLC (FKA BIONICA LABS) 2023 second_quarter MED Educated key government stakeholders on Bionicas activities and technologies in support of the Armed Forces. Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2023-07-16T22:01:54-04:00
3006108 CORNERSTONE GOVERNMENT AFFAIRS, INC. 894f6bb5-6a7c-42bd-be27-7eace624b3a4 Q2 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 MEDICAL TECHNOLOGY ENTERPRISE CONSORTIUM 2023 second_quarter MED Educated key government stakeholders on the Medical Technology Enterprise Consortiums activities and partnership model in support of Servicemember health and readiness. Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE     0 0 2023-07-16T22:10:57-04:00
3006111 CORNERSTONE GOVERNMENT AFFAIRS, INC. 19099a81-3597-44b2-8bad-a99788d07f20 Q2 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 SCIPERIO INC. 2023 second_quarter MED Educated key government stakeholders on Sciperio, Inc.s technology and manufacturing capabilities in support of the Department of Defense. Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2023-07-16T22:14:42-04:00
3006113 CORNERSTONE GOVERNMENT AFFAIRS, INC. 77412b82-a1eb-4d7c-816e-49f8455a1457 Q2 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 SMITH & NEPHEW 2023 second_quarter MED Educated key government stakeholders on Smith+Nephew products applicable to the military. HOUSE OF REPRESENTATIVES,SENATE     0 0 2023-07-16T22:17:07-04:00
3006117 CORNERSTONE GOVERNMENT AFFAIRS, INC. 65f4ff14-79d5-4850-96a7-a7aea3a04229 Q2 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 THE GENEVA FOUNDATION 2023 second_quarter MED Educated key government stakeholders on The Geneva Foundations research and development activities in support of US Service members. Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2023-07-16T22:21:05-04:00
3006119 CORNERSTONE GOVERNMENT AFFAIRS, INC. 8ee01a89-d5b8-41af-85c2-478cb1055bee Q2 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 THE REGENTS OF THE UNIVERSITY OF COLORADO OBO UNIVERSITY OF COLORADO ANSCHUTZ 2023 second_quarter MED Educated key government stakeholders on the University of Colorados medical capabilities in areas applicable to military health and readiness. Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2023-07-16T22:23:16-04:00
3006468 COVINGTON & BURLING LLP 49de3510-0c15-4147-a741-31795b807177 Q2 COVINGTON & BURLING LLP 11195 SL 2T, LLC ("SMARTLABS") 2023 second_quarter MED Education and support for policies and funding to advance turnkey, co-located, on-demand pharma grade research laboratory environments, including the House and Senate Pandemic and All-Hazards Preparedness Reauthorization Act (PAHPA) Re-authorization and the Senate National Defense Authorization Act. HOUSE OF REPRESENTATIVES,SENATE 90000   0 0 2023-07-17T10:35:02-04:00
3006500 STRATEGIC MARKETING INNOVATIONS 4343c8ab-0d12-4636-80f0-7331ecd58f2a Q2 STRATEGIC MARKETING INNOVATIONS 60550 ICHOR SCIENCES 2023 second_quarter MED Defense appropriations programmatic add Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2023-07-17T10:42:16-04:00
3006514 STRATEGIC MARKETING INNOVATIONS 34e14d33-a79b-4697-984a-03922dca1939 Q2 STRATEGIC MARKETING INNOVATIONS 60550 PSYONIC 2023 second_quarter MED Receive DoD medical research funding on how to best apply prosthetic to the nervous system Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2023-07-17T10:44:45-04:00
3006654 BARKER LEAVITT, PLLC (SKA MR. JAMES C. BARKER) df49ebb8-7d99-4539-9e8b-e60ac1edfbe1 Q2 BARKER LEAVITT, PLLC (SKA MR. JAMES C. BARKER) 292538 SONIC HEALTHCARE USA 2023 second_quarter MED Issues relating to the regulation of laboratory developed tests, the VALID Act, issues relating to PAMA (the SALSA Bill), federal policies relating to the implementation of the anti-kickback requirements of the Support for Patients and Communities Act. Physician Lab Fee schedule. Anatomic Fee Schedule and Surprise Billing. COVID Testing and billing procedures. COVID Vaccine Federal Mandate. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2023-07-17T11:26:20-04:00
3007136 ALPINE ADVISORS b1fbde76-e6c9-47d0-931f-bd817e3f829d Q2 ALPINE ADVISORS 401106595 COALITION FOR CANNABIS POLICY, EDUCATION AND REGULATION 2023 second_quarter MED Issues pertaining to government-wide federal regulation of cannabis HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2023-07-17T13:47:33-04:00
3007521 O'NEILL AND ASSOCIATES 76a3a134-6da0-44dc-87dd-f2b77801c196 Q2 O'NEILL AND ASSOCIATES 73134 POINT32HEALTH SERVICES, INC. (FORMERLY TUFTS HEALTH PLAN) 2023 second_quarter MED Healthcare, Medical HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2023-07-17T15:05:08-04:00
3007649 IGM BIOSCIENCES, INC. 792182d8-1de6-4d73-8e21-7b44be27a39a Q2 IGM BIOSCIENCES, INC. 401106312 IGM BIOSCIENCES, INC. 2023 second_quarter MED COVID Supplemental Appropriation S.2076/H.R.3932 - PASTEUR Act of 2021 S.3799 - PREVENT Pandemics Act Issues related to the development of an antibody therapy for COVID-19 Issues related to antimicrobial resistance (AMR) and drug development Issues related to supply chain and biopharmaceutical manufacturing FY2024 Defense Appropriations Issues related to the reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA) National Biodefense Strategy and Implementation Plan H.R.3746 Fiscal Responsibility Act of 2023 H.R.4421 Preparing for All Hazards and Pathogens Reauthorization Act Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   230000 0 0 2023-07-17T15:21:17-04:00
3007685 MCCARTHY STRATEGIC SOLUTIONS 44aa6361-a9b5-4470-940c-00fcc007ba7f Q2 MCCARTHY STRATEGIC SOLUTIONS 300936 INOTIV, INC. 2023 second_quarter MED Animal research models to biopharmaceuticals, academic and government research for realizing life saving medications HOUSE OF REPRESENTATIVES,SENATE     0 0 2023-07-17T15:29:46-04:00
3007694 MCCARTHY STRATEGIC SOLUTIONS acd750d5-b246-4195-9172-d59157f89797 Q2 MCCARTHY STRATEGIC SOLUTIONS 300936 INOTIV, INC. 2023 second_quarter MED Animal research models to biopharmaceuticals, academic and government research for realizing life saving medications HOUSE OF REPRESENTATIVES,SENATE     0 0 2023-07-17T15:31:06-04:00
3008588 CORNERSTONE GOVERNMENT AFFAIRS, INC. 8f0eb155-ece8-4c93-a88c-1600e5808d25 Q2 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 OU MEDICINE, INC. 2023 second_quarter MED Research and development of medical programs in partnership with Department of Health and Human Services and other federal agencies HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2023-07-17T21:20:45-04:00
3008776 AMERICAN SOCIETY OF ADDICTION MEDICINE 3a9109a2-3f93-4ed7-adba-8c1abba28004 Q2 AMERICAN SOCIETY OF ADDICTION MEDICINE 401104864 AMERICAN SOCIETY OF ADDICTION MEDICINE 2023 second_quarter MED Advocated for increased FY24 funding for HRSA's Addiction Medicine Fellowship Program ($30M) Advocated for increased FY24 funding for HRSA's Substance Use Disorder Treatment and Recovery Loan Repayment Program ($50M) Advocated for (S. 644/H.R. 1359) the Modernizing Opioid Treatment Access Act, which would allow specially registered opioid treatment program clinicians and addiction specialist physicians to prescribe methadone for OUD that can be picked up from pharmacies, subject to federal regulation or guidance on supply of methadone for unsupervised use. Advocated for S. 1165/ HR 2400- the Reentry Act, which would allow states to provide Medicaid coverage to eligible individuals up to 30 days prior to release from incarceration Advocated for HR 3074/S.971 - Due Process Continuity of Care Act, which would amend title XIX of the Social Security Act to remove the Medicaid coverage exclusion for inmates in custody pending disposition of charges, and for other purposes. Worked on draft legislation that would provide Medicare coverage for evidence-based residential SUD services Worked on draft legislation that would make permanent a state plan amendment option related to Medicaid's IMD exclusion Supported H.R.1502 - Comprehensive Opioid Recovery Centers Reauthorization Act of 2023, in its entirety Advocated for removal of in-person evaluation requirement in proposed telemedicine rules by the DEA and worked on related draft legislation Opposed proposed changes to the STAR-LRP program in S.462 - the Mental Health Professionals Workforce Shortage Loan Repayment Act of 2023 Advocated for removal of a lifetime ban that prevents individuals convicted of a drug felony from receiving Supplemental Nutritional Assistance Program (SNAP) or Temporary Assistance for Needy Families TANF) as part of the next Farm Bill. Advocated for various substance use disorder workforce and coverage policy changes, including some of which appear in H.R. 4531, the Support for Patients and Communities Reauthorization Act. Joined coalition letter s… Centers For Medicare and Medicaid Services (CMS),Congressional Budget Office (CBO),Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Office of Natl Drug Control Policy (NDCP),SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA)   50000 0 0 2023-07-18T05:49:41-04:00
3008905 THE CONSILIO GROUP 30a90796-6597-4756-9cb9-f576680675ac Q2 THE CONSILIO GROUP 400374717 DETECTACHEM 2023 second_quarter MED Colorimetric explosive and narcotic detection capabilities Air Force, Dept of,Defense, Dept of (DOD),Education, Dept of,Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Navy, Dept of,SENATE,White House Office 16500   0 0 2023-07-18T09:17:15-04:00
3009396 WATKINS & EAGER PLLC 89f1a5b1-28f4-43fe-9adf-797efa1c703f Q2 WATKINS & EAGER PLLC 401104403 NATIONAL FRAGILE X FOUNDATION 2023 second_quarter MED Assist in matters necessary for Advocacy Day planning on The Hill; Arrange meetings and appointments for NFXF officials; Work to encourage Members to act favorably on matters of interest and benefit to NFXF; Encourage Members to meet with constituents impacted by Fragile X. HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2023-07-18T10:50:51-04:00
3009520 COVINGTON & BURLING LLP 4f1d82c9-905c-47fd-bb63-3cdd3a974fb9 Q2 COVINGTON & BURLING LLP 11195 AMERICAN CLINICAL LABORATORY ASSOCIATION (ACLA) 2023 second_quarter MED Food and Drug Administration (FDA) policies related to diagnostics and laboratory regulation. Food & Drug Administration (FDA) 30000   0 0 2023-07-18T11:11:40-04:00
3009537 DANA-FARBER CANCER INSTITUTE f0bb824a-1886-4880-8d5b-9ad12cb37b56 Q2 DANA-FARBER CANCER INSTITUTE 401106163 DANA-FARBER CANCER INSTITUTE 2023 second_quarter MED Support policies to remove barriers to clinical trials, promote research generally, address issues in childhood cancer research including Gabriella Miller Kids First Research Act 2.0 (HR 3391, S 1624); Accelerating Kids Access to Care Act(HR 3089, S 1544) HOUSE OF REPRESENTATIVES,SENATE   30156 0 0 2023-07-18T11:14:08-04:00
3009636 AMERICAN CLINICAL LABORATORY ASSN e09bcadb-8d8e-4e02-a06a-815b2f44dd7b Q2 AMERICAN CLINICAL LABORATORY ASSN 1923 AMERICAN CLINICAL LABORATORY ASSN 2023 second_quarter MED Reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, new test coding and pricing, definitive drug testing coding, coverage, and payment, and implementation of the Protecting Access to Medicare Act (P.L. 113-93); FDA and CMS policies related to diagnostics and laboratory regulation; reauthorization of the Pandemics and All-Hazards Preparedness Act (PL. 109-417); price transparency for clinical laboratory services, FY 2024 budget and appropriations processes Saving Access to Laboratory Services Act H.R. 2377/S. 1000, VALID Act H.R. 2369; H.R. 3791, Improving Data in Public Health Act; H.R. 3248, Diagnostic Lab Testing Transparency Act; Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office   633739 0 0 2023-07-18T11:26:24-04:00
3009738 UNIVERSITY OF MARYLAND, BALTIMORE (UMB) df7f93e0-ccb1-4148-884a-3af6b18b1835 Q2 UNIVERSITY OF MARYLAND, BALTIMORE (UMB) 401103161 UNIVERSITY OF MARYLAND, BALTIMORE (UMB) 2023 second_quarter MED ARPA-H, budget and agency location Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   10000 0 0 2023-07-18T11:38:22-04:00
3010067 NATIONAL ASSOCIATION FOR BIOMEDICAL RESEARCH 714c205a-b58d-45d3-83ba-335eb1167738 Q2 NATIONAL ASSOCIATION FOR BIOMEDICAL RESEARCH 26557 NATIONAL ASSOCIATION FOR BIOMEDICAL RESEARCH 2023 second_quarter MED Support funding for biomedical research HOUSE OF REPRESENTATIVES,SENATE   30000 0 0 2023-07-18T12:45:30-04:00
3010135 MARSHFIELD CLINIC HEALTH SYSTEM b95e7b55-c1b7-4b0b-8a08-d2a7e46a7a1c Q2 MARSHFIELD CLINIC HEALTH SYSTEM 57830 MARSHFIELD CLINIC HEALTH SYSTEM 2023 second_quarter MED research support, agriculture, farm safety, child care and agriculture communities HOUSE OF REPRESENTATIVES,SENATE   60000 0 0 2023-07-18T12:58:48-04:00
3010142 BURRELL INTERNATIONAL GROUP LLC 91fcacbd-af08-41a4-9840-105eeb36852b Q2 BURRELL INTERNATIONAL GROUP LLC 401103483 ARSENAL MEDICAL, INC. 2023 second_quarter MED Funding for medical devices for hemorrhage; Provisions in FY24 NDAA and FY24 Defense Appropriations HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2023-07-18T12:59:03-04:00
3010144 ALPINE GROUP PARTNERS, LLC. f9651e0f-e5eb-41c4-9bd7-0d66b9b58554 2T ALPINE GROUP PARTNERS, LLC. 1171 MINDBLOOM, INC. 2023 second_quarter MED Telehealth legislation and regulation Mental health policy HOUSE OF REPRESENTATIVES,SENATE 70000   0 1 2023-07-18T13:00:13-04:00
3010185 FEDERAL SOLUTIONS, LLC ffbdc428-da1c-4cc1-acc4-edd978b040a8 Q2 FEDERAL SOLUTIONS, LLC 311371 MISSISSIPPI STATE UNIVERSITY 2023 second_quarter MED Labor/HHS/Education Appropriations: Provisions relating to disease research HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2023-07-18T13:07:55-04:00
3010308 DA VINCI GROUP 2ef09d2a-f13c-4cb4-8a86-da62759ee21a Q2 DA VINCI GROUP 11548 KAI MEDICAL LABORATORY 2023 second_quarter MED Funding for Clinical Research & Diagnostics Programs HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2023-07-18T13:28:35-04:00
3010312 DA VINCI GROUP 227d9168-01f5-495c-8c21-681a39a46b32 Q2 DA VINCI GROUP 11548 KAI MEDICAL LABORATORY 2023 second_quarter MED Funding for Clinical Research & Diagnostics Programs HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2023-07-18T13:28:56-04:00
3010614 WINNING STRATEGIES WASHINGTON e1b19dc6-4ede-4a64-a815-c33879628920 Q2 WINNING STRATEGIES WASHINGTON 50796 DIABETES PATIENT ADVOCACY COALITION 2023 second_quarter MED Issues related to treatment of diabetes and support for diabetes patients HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2023-07-18T14:18:48-04:00
3010695 IMPACT HEALTH POLICY PARTNERS 668732f0-71df-465b-a701-9114931f5e4b Q2 IMPACT HEALTH POLICY PARTNERS 401104696 ABBOTT LABORATORIES 2023 second_quarter MED Issues related to coverage and reimbursement for durable medical equipment, medical devices, diagnostics and nutrition. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2023-07-18T14:27:29-04:00
3010712 IMPACT HEALTH POLICY PARTNERS 235081ea-c017-400e-88fe-4fe2a9836ef8 Q2 IMPACT HEALTH POLICY PARTNERS 401104696 CHILDREN'S HOSPITAL COLORADO 2023 second_quarter MED Issues related to pediatric research and children's hospital graduate medical education. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2023-07-18T14:29:43-04:00
3010756 IMPACT HEALTH POLICY PARTNERS e2c54c58-aa41-44ac-abbe-18aad6d51cd6 Q2 IMPACT HEALTH POLICY PARTNERS 401104696 HACKENSACK MERIDIAN HEALTH 2023 second_quarter MED Issues related to research funding, including ARPA-H, NIH, organ transplants, and other matters. HOUSE OF REPRESENTATIVES,SENATE,White House Office 40000   0 0 2023-07-18T14:35:03-04:00
3010843 THE JACKSON LABORATORY d5728a3a-4b39-42a6-8290-a2721e5919b2 Q2 THE JACKSON LABORATORY 401104723 THE JACKSON LABORATORY 2023 second_quarter MED Issues related to biomedical research. Animal model use in biomedical research. HOUSE OF REPRESENTATIVES,Office of Science & Technology Policy (OSTP),SENATE   30000 0 0 2023-07-18T14:44:09-04:00
3010895 PARALYZED VETERANS OF AMERICA 44db5f05-a6b2-42f0-affe-41785d38ca8c Q2 PARALYZED VETERANS OF AMERICA 30724 PARALYZED VETERANS OF AMERICA 2023 second_quarter MED Discussions: Department of Veterans Affairs, Medical Research Issues Discussions: National Institutes of Health, Medical Research Issues HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,Veterans Affairs, Dept of (VA)   90668 0 0 2023-07-18T14:50:45-04:00

Next page

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE lobbying_activities (
            id INTEGER PRIMARY KEY,
            filing_uuid TEXT NOT NULL,
            filing_type TEXT NOT NULL,
            registrant_name TEXT NOT NULL,
            registrant_id INTEGER,
            client_name TEXT NOT NULL,
            filing_year INTEGER NOT NULL,
            filing_period TEXT NOT NULL,
            issue_code TEXT,
            specific_issues TEXT,
            government_entities TEXT,
            income_amount INTEGER,
            expense_amount INTEGER,
            is_no_activity INTEGER DEFAULT 0,
            is_termination INTEGER DEFAULT 0,
            received_date TEXT,
            CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
                REFERENCES lobbying_filings_raw(filing_uuid)
        );
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);
Powered by Datasette · Queries took 6571.167ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API